BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17673197)

  • 21. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K; Salemyr J; Zachrisson I; Carlsson-Skwirut C; Ortqvist E; Bang P
    Diabetes Care; 2007 Jun; 30(6):1357-63. PubMed ID: 17372150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Mälarstig A; Brismar K; Hamsten A; Fisher RM; Hellénius ML
    Clin Sci (Lond); 2009 Mar; 116(6):507-12. PubMed ID: 18816247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
    Plengpanich W; Mangkala J; Buranasukajorn P; Boonruang K; Sunthornyothin S; Suwanwalaikorn S; Khovidhunkit W; Sridama V; Snabboon T
    J Med Assoc Thai; 2008 Nov; 91(11):1681-4. PubMed ID: 19127789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
    Löfqvist C; Andersson E; Gelander L; Rosberg S; Hulthen L; Blum WF; Wikland KA
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1420-7. PubMed ID: 15598696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
    Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
    Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
    Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimens.
    Elmlinger MW; Zwirner M; Kühnel W
    Clin Lab; 2005; 51(3-4):145-52. PubMed ID: 15819169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.
    Turan S; Bereket A; Furman A; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
    Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
    Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
    Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
    Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
    Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
    Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence.
    Xu S; Gu X; Pan H; Zhu H; Gong F; Li Y; Xing Y
    Endocr J; 2010; 57(3):221-8. PubMed ID: 20051649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reference values of IGF-I in children from birth to 5 years of age, in Burkina Faso, using blood samples on filter paper.
    Kouanda S; Tonglet R; De Coninck V; Doulougou B; Sondo B; Ketelslegers JM; Robert A
    Growth Horm IGF Res; 2008 Aug; 18(4):345-52. PubMed ID: 18329308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reference norms of IGF binding proteins in a healthy adult population in the Czech Republic].
    Lacinová Z; Justová V
    Sb Lek; 2002; 103(2):141-7. PubMed ID: 12688135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cord blood IGF-1 and IGFBP-3 levels in asphyxiated term newborns.
    Dinleyici EC; Tekin N; Colak O; Aksit MA
    Neuro Endocrinol Lett; 2006 Dec; 27(6):745-7. PubMed ID: 17187018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.